Euclidean Capital as of Sept. 30, 2022
Portfolio Holdings for Euclidean Capital
Euclidean Capital holds 10 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| 23andme Holding Class A Com | 27.2 | $29M | 10M | 2.86 | |
| Pmv Pharmaceuticals (PMVP) | 25.8 | $28M | 2.3M | 11.90 | |
| Foghorn Therapeutics (FHTX) | 10.0 | $11M | 1.3M | 8.58 | |
| Rapt Therapeutics | 9.7 | $10M | 433k | 24.06 | |
| Ngm Biopharmaceuticals | 9.1 | $9.8M | 747k | 13.08 | |
| Alector (ALEC) | 8.6 | $9.3M | 981k | 9.46 | |
| First Financial Ban (FFBC) | 3.4 | $3.7M | 174k | 21.08 | |
| Tenaya Therapeutics (TNYA) | 2.5 | $2.7M | 916k | 2.90 | |
| Oric Pharmaceuticals (ORIC) | 2.2 | $2.4M | 748k | 3.20 | |
| Surrozen | 1.5 | $1.6M | 803k | 2.02 |
